Literature DB >> 3536200

Clinical diabetic nephropathy: natural history and complications.

A Grenfell, P J Watkins.   

Abstract

Diabetic nephropathy develops in about 45% of insulin dependent diabetics of whom two-thirds will develop renal failure, the rest dying from cardiovascular disease. Most of the excess mortality of insulin dependent diabetics occurs in those with proteinuria. Among non-insulin dependent diabetics nephropathy is also an important cause of increased mortality but this is mainly from cardiovascular disease. Once diabetic nephropathy is established it progresses relentlessly to end-stage renal failure over about seven years, but ranging from five to 20 years. The explanation for the different rates of progression in individual patients is not understood. Hypertension accompanies diabetic nephropathy and its treatment may retard the progression of renal failure. Other forms of intervention include glycaemic control which has not been shown to have any effect, and protein restriction for which no conclusions can be drawn at present. The diagnosis of diabetic nephropathy is straightforward in the presence of a typical history and clinical features. Non-diabetic renal disease is sometimes the cause of renal failure and may require specific treatment; prognosis for renal failure treatment may be better than for nephropathy patients with other diabetic complications. Other diabetic complications develop as diabetic nephropathy progresses, most notably cardiac and peripheral vascular disease. Proliferative retinopathy and neuropathy are considerable problems and their management needs attention both before and after renal failure treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3536200     DOI: 10.1016/s0300-595x(86)80074-3

Source DB:  PubMed          Journal:  Clin Endocrinol Metab        ISSN: 0300-595X


  9 in total

1.  Microalbuminuria in systemic sclerosis.

Authors:  A Dawnay; A G Wilson; E Lamb; J D Kirby; W R Cattell
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

Review 2.  Costs of insulin-dependent diabetes mellitus.

Authors:  T T Simell; H Sintonen; J Hahl; O G Simell
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

Review 3.  Perindopril safety and tolerance in at-risk patients.

Authors:  S Brichard; A E Lambert
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Plasma C-peptide response to oral glucose load in hyperthyroidism.

Authors:  E Bonora; V Manicardi; M Zenere; P Moghetti; C Coscelli; M Muggeo
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

5.  Clinical and pathological analysis of renal damage in elderly patients with type 2 diabetes mellitus.

Authors:  Shuang-Tong Yan; Jun-Yan Liu; Hui Tian; Chun-Lin Li; Jian Li; Ying-Hong Shao; Huai-Yin Shi; Yu Liu; Yan-Ping Gong; Fu-Sheng Fang; Ban-Ruo Sun
Journal:  Clin Exp Med       Date:  2015-06-09       Impact factor: 3.984

6.  Thickness of glomerular and tubular basement membranes in preclinical and clinical stages of diabetic nephropathy.

Authors:  I Tyagi; U Agrawal; V Amitabh; A K Jain; S Saxena
Journal:  Indian J Nephrol       Date:  2008-04

7.  Autonomic neuropathy and survival in diabetes mellitus: effects of pancreas transplantation.

Authors:  X Navarro; W R Kennedy; D E Sutherland
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

8.  Microalbuminuria in patients with rheumatoid arthritis.

Authors:  L M Pedersen; H Nordin; B Svensson; H Bliddal
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

9.  Correlation between microalbuminuria and urinary copper in type two diabetic patients.

Authors:  Afsaneh Talaei; Saber Jabari; Mohamad Hasan Bigdeli; Heidar Farahani; Mansour Siavash
Journal:  Indian J Endocrinol Metab       Date:  2011-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.